SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-18-003331
Filing Date
2018-11-09
Accepted
2018-11-09 16:31:04
Documents
45
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT xenetic_10q-093018.htm 10-Q 255824
2 CERTIFICATION xenetic_10q-ex3101.htm EX-31.1 9179
3 CERTIFICATION xenetic_10q-ex3102.htm EX-31.2 9604
4 CERTIFICATION xenetic_10q-ex3201.htm EX-32.1 4215
  Complete submission text file 0001683168-18-003331.txt   1455636

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE xbio-20180930.xml EX-101.INS 175836
6 XBRL SCHEMA FILE xbio-20180930.xsd EX-101.SCH 19457
7 XBRL CALCULATION FILE xbio-20180930_cal.xml EX-101.CAL 33340
8 XBRL DEFINITION FILE xbio-20180930_def.xml EX-101.DEF 67896
9 XBRL LABEL FILE xbio-20180930_lab.xml EX-101.LAB 135785
10 XBRL PRESENTATION FILE xbio-20180930_pre.xml EX-101.PRE 112667
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37937 | Film No.: 181173494
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1